Practical Considerations and Outcomes of Inter-facility ECMO Transfer of COVID-19 Patients During a Pandemic: The Mayo Clinic Experience

Sen, Ayan; Blakeman, Stephanie; DeValeria, Patrick A.; Peworski, Dominique; Lanza, Louis A.; Downey, Francis X.; Alwardt, Cory M.; Dobberpuhl, Jeffrey G.; DeMarco, Matthew; Callisen, Hannelisa; Shively, Jennifer; McKay, Kelly; Singbartl, Kai; Sell-Dottin, Kristen A.; D’Cunha, Jonathan; Patel, Bhavesh M.

Inter-facility transport of a critically ill patient with Acute Respiratory Distress Syndrome (ARDS) may be necessary for a higher level of care and/or initiation of extracorporeal membrane oxygenation (ECMO). During the COVID19 pandemic, ECMO has been used for patients with severe ARDS with successful results. Transporting a patient after ECMO cannulation by the receiving facility brings forth logistic challenges including availability of adequate Personal Protective Equipment (PPE) for the transport team and hospital capacity management issues. We report our designated ECMO transport team’s experience with five patients with COVID19 associated severe ARDS after cannulation at the referring facility. Focusing on transport associated logistics, creation of checklists, and collaboration with EMS partners is necessary for safe and good outcomes for patients while maintaining team safety.